Michielin O, Lalani A, Robert C, et al. Defining unique clinical hallmarks for immune checkpoint inhibitor-based therapies. J Immunother Cancer 2022;10:e003024. doi: 10.1136/jitc-2021-003024
Figures 1 and 6 have been updated. References 155 and 157 have been updated.